Korean J Pain.  2014 Oct;27(4):365-366. 10.3344/kjp.2014.27.4.365.

Curcumin, COX-2, and Protein p300/CBP

• Jung KT
• Lim KJ

• KMID: 1802504
• DOI: http://doi.org/10.3344/kjp.2014.27.4.365

Abstract

No abstract available.

MeSH Terms

Curcumin*
Curcumin

Reference

1. Kapoor S. Curcumin and its emerging role in pain modulation and pain management. Korean J Pain. 2012; 25:202–203. PMID: 22787555.

2. Moini Zanjani T, Ameli H, Labibi F, Sedaghat K, Sabetkasaei M. The attenuation of pain behavior and serum COX-2 concentration by curcumin in a rat model of neuropathic pain. Korean J Pain. 2014; 27:246–252. PMID: 25031810.

3. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009; 41:40–59. PMID: 18662800.

4. Mukherjee SP, Behar M, Birnbaum HA, Hoffmann A, Wright PE, Ghosh G. Analysis of the RelA:CBP/p300 interaction reveals its involvement in NF-κB-driven transcription. PLoS Biol. 2013; 11:e1001647. PMID: 24019758.

5. Zhu X, Li Q, Chang R, Yang D, Song Z, Guo Q, et al. Curcumin alleviates neuropathic pain by inhibiting p300/CBP histone acetyltransferase activity-regulated expression of BDNF and cox-2 in a rat model. PLoS One. 2014; 9:e91303. PMID: 24603592.